Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist

Combination of a 5-HT reuptake inhibitor and a H5-HT1B anatagonist or partial agonist

US Patent 6159971 · Granted Dec 12, 2000

Estimated economic value: $8,539,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process and apparatus for oxidizing organic compounds2013
Compounds2010
3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (G2010
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Compounds having selective inhibiting effect at GSK32009
Substituted indan derivatives2008
Substituted indan derivatives2008
Substituted indan derivatives2008
3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-32008
Substituted chroman derivatives2008
Substituted chroman derivatives2008